mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.042 |
0.3 |
mRNA |
tivantinib |
CTRPv2 |
pan-cancer |
AAC |
0.054 |
0.3 |
mRNA |
methylstat |
CTRPv2 |
pan-cancer |
AAC |
0.049 |
0.3 |
mRNA |
BRD-A86708339 |
CTRPv2 |
pan-cancer |
AAC |
0.06 |
0.3 |
mRNA |
ifosfamide |
CTRPv2 |
pan-cancer |
AAC |
-0.062 |
0.3 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.039 |
0.3 |
mRNA |
ciclopirox |
CTRPv2 |
pan-cancer |
AAC |
0.038 |
0.3 |
mRNA |
BRD-K41597374 |
CTRPv2 |
pan-cancer |
AAC |
0.041 |
0.3 |
mRNA |
TPCA-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.038 |
0.3 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.038 |
0.3 |